María Guadalupe Miranda-Novales1,2, Karen Flores-Moreno1, Yolanda López-Vidal3, Mauricio Rodríguez-Álvarez3, Fortino Solórzano-Santos4, José Luis Soto-Hernández5, Samuel Ponce de León-Rosales6. 1. Laboratorio de Microbioma, Facultad de Medicina, Universidad Nacional Autónoma de México. Mexico City, Mexico. 2. Unidad de Investigación en Análisis y Síntesis de la Evidencia, Instituto Mexicano del Seguro Social. Mexico City, Mexico. 3. Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México. Mexico City, Mexico. 4. Unidad de Investigación de Medicina Basada en Evidencias, Hospital Infantil de México Dr. Federico Gómez. Mexico City, Mexico. 5. Instituto Nacional de Neurología y Neurocirugía Dr. Manuel Velasco Suárez. Mexico City, Mexico. 6. Universidad Nacional Autónoma de México. Mexico City, Mexico.
Abstract
OBJECTIVE: To establish the current situation of antimicrobial resistance and antibiotic consumption in Mexican hospitals. MATERIALS AND METHODS: Antimicrobial susceptibility data from blood and urine isolates were collected. Defined daily dose (DDD) of antibiotic consumption/100 occupied beds (OBD) was calculated. RESULTS: Study period: 2016 and 2017. Of 4 382 blood isolates, E. coli and K. pneumoniae were most frequently reported, with antimicrobial resistance >30% for most drugs tested, only for carbapenems and amikacin resistance were <20%. A. baumannii had antimicrobial resistance >20% to all drugs. Resistance to oxacillin in S. aureus was 20%. From 12 151 urine isolates, 90% corresponded to E. coli; resistance to ciprofloxacin, cephalosporins and trimethoprim/sulfamethoxazole was >50%, with good susceptibility to nitrofurantoin, amikacin and carbapenems. Global median antimicrobial consumption was 57.2 DDD/100 OB. CONCLUSIONS: s. This report shows a high antimicrobial resistance level in Gram-negative bacilli and provides an insight into the seriousness of the problem of antibiotic consumption.
OBJECTIVE: To establish the current situation of antimicrobial resistance and antibiotic consumption in Mexican hospitals. MATERIALS AND METHODS: Antimicrobial susceptibility data from blood and urine isolates were collected. Defined daily dose (DDD) of antibiotic consumption/100 occupied beds (OBD) was calculated. RESULTS: Study period: 2016 and 2017. Of 4 382 blood isolates, E. coli and K. pneumoniae were most frequently reported, with antimicrobial resistance >30% for most drugs tested, only for carbapenems and amikacin resistance were <20%. A. baumannii had antimicrobial resistance >20% to all drugs. Resistance to oxacillin in S. aureus was 20%. From 12 151 urine isolates, 90% corresponded to E. coli; resistance to ciprofloxacin, cephalosporins and trimethoprim/sulfamethoxazole was >50%, with good susceptibility to nitrofurantoin, amikacin and carbapenems. Global median antimicrobial consumption was 57.2 DDD/100 OB. CONCLUSIONS: s. This report shows a high antimicrobial resistance level in Gram-negative bacilli and provides an insight into the seriousness of the problem of antibiotic consumption.
Entities:
Keywords:
anti-bacterial agents; drug resistance; drug utilization; microbial
Authors: Federico A Zumaya-Estrada; Alfredo Ponce-de-León-Garduño; Edgar Ortiz-Brizuela; Juan Carlos Tinoco-Favila; Patricia Cornejo-Juárez; Diana Vilar-Compte; Alejandro Sassoé-González; Pedro Jesus Saturno-Hernandez; Celia M Alpuche-Aranda Journal: Infect Drug Resist Date: 2021-11-02 Impact factor: 4.003
Authors: Efrén Murillo-Zamora; Xóchitl Trujillo; Miguel Huerta; Oliver Mendoza-Cano; José Guzmán-Esquivel; José Alejandro Guzmán-Solórzano; María Regina Ochoa-Castro; Alan Gabriel Ortega-Macías; Andrea Lizeth Zepeda-Anaya; Valeria Ruiz-Montes de Oca; Mónica Ríos-Silva; Agustin Lugo-Radillo Journal: Antibiotics (Basel) Date: 2022-06-02